• Explore /
  • Poster
  • / <span>Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).</span>

Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).

Abstract Poster

Authors

null

Seung Kim

Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea

Seung Kim , Young-Woong Won , Jung Hoon Kim , Joon Ho Park

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Translational Research

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 65)

DOI

10.1200/jco.2016.34.4_suppl.65

Abstract #

65

Poster Bd #

H21

Abstract Disclosures

Similar Posters

First Author: Min-Young Lee

First Author: Ilya Tsimafeyeu

First Author: Josep Tabernero

First Author: Shunji Endo